Menu

Insulin Cost Caps Gaining Support Amid Rising Prices

12 hours ago 0

The Kritzberger family has a long history of farming in the Red River Valley, pivoting from livestock to cultivating sugar beets, soybeans, and grains. Financial challenges are a consistent burden for them, as highlighted by Ang Kritzberger, who expressed, “We’re in an incredible amount of debt.”

Adding to their financial stress, their daughter Nina has Type 1 diabetes, which has placed them in the midst of the national dialogue about insulin costs. Diagnosed at age 7, Nina’s condition required constant monitoring. Ang Kritzberger recounted, “I slept by her bedside for the first 60 days,” emphasizing the need for round-the-clock care.

The Kritzbergers face significant medical expenses, paying over $8,000 annually for drugs and supplies, despite having insurance. Many others share this struggle, as insulin prices have surged, forcing some to ration the drug, leading to severe health risks.

“Typically, Republicans are more on the free-market side of things, Democrats are more supportive of intervening,” explained North Dakota state Sen. Sean Cleary.

A growing movement seeks to cap insulin costs, uniting Democrats and Republicans in a rare bipartisan effort. Legislation capping costs at $25 a month was introduced by Cleary and passed in North Dakota, one of 29 states to enact such measures.

Patients with diabetes represent about one-fifth of the 40 million Americans who need insulin. Although the average yearly out-of-pocket cost has decreased from $470 in 2018 to $220 in 2025 for those with private insurance, the future price cap offers families like the Kritzbergers some financial relief and stability.

Nina Kritzberger, now 17, manages her diabetes with various equipment, worrying about potential failures that could require her to take immediate action. “If my pump doesn’t work, I need a testing kit… What if I go low?”

The push for capping costs gained momentum in 2019 when Colorado implemented the first insulin copay cap. Later, federal legislation capped prices for Medicare enrollees, though attempts to extend this to private insurance met resistance from Republicans.

Initially, North Dakota’s insulin cap faced challenges, primarily due to opposition from health insurers and the business community. They argued that reducing costs for diabetics would hike premiums for others.

Despite initial reservations, testimonies from families like the Kritzbergers emphasized the unworkability of the insulin market. The legislation eventually passed with widespread bipartisan support.

Although state caps do not apply to all health plans, public opinion supports regulating drug prices. A KFF survey found that 77% of Democrats and 68% of Republicans believe more government action is necessary.

Efforts for a national insulin price cap continue, reflecting an ongoing bipartisan initiative in Congress. For families like the Kritzbergers, the debate underscores the importance of community and finding common ground. Ang Kritzberger commented on the connections in North Dakota, demonstrating community support amidst their struggles.

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *